¶¶ÒõÂÃÐÐÉä

Medical student Daniel Youmans (left) and Tom Cech (right), director of the BioFrontiers Institute, look over an image from a high-powered microscope (Credit: Glenn Asakawa/¶¶ÒõÂÃÐÐÉä Boulder)Forty years after researchers first discovered it in fruit flies

As part of BioFrontiers Institute Professor John Rinn’s biochemistry class, this week graduate students performed an RNA splicing interpretive dance on the west lawn of the Jennie Smoly Caruthers Biotech Building. ¶¶ÒõÂÃÐÐÉä Nobel Laureate and

After years of companies being sold off or growing and relocating, Boulder’s life-sciences sector is showing signs of reaching critical mass.Companies such as Clovis Oncology Inc. (Nasdaq: CLVS), SomaLogic Inc., Array Biopharma Inc. (Nasdaq: ARRY)

Nobel Laureate Professor Tom Cech came to the Department of Chemistry on 16th October, to give the 2017 Herchel Smith Lecture: 'Shedding some Light on the Dark Matter of the Genomic Universe.'Professor Cech is Distinguished

University of Colorado Boulder Distinguished Professor Tom Cech, Colorado’s first Nobel Prize winner, has been named the 2017 Hazel Barnes Prize winner – the most distinguished award a faculty member can receive from the university.Cech, the

 A deep look inside the live cells reveals a key cancer process Telomerase, a powerful enzyme found at the ends of chromosomes, can keep humans healthy, or promote cancer growth. Researchers at the University of Colorado in Boulder used a

John Milligan spent two years at the University of Colorado Boulder during his graduate studies in the mid-1980’s. He helped to move his mentor, Dr. Olke Uhlenbeck, in a U-Haul truck across the Great Plains to the Rockies. Uhlenbeck was recruited

Among cancers, scientists have spent their entire research careers looking for cellular similarities that may lead to a single cure for many cancers –– the rare chance to have a single answer to a multifaceted problem. In 1997, scientists discovered

In a new paper released today in Nature, BioFrontiers Institute scientists at the University of Colorado in Boulder, Tom Cech and Leslie Leinwand, detailed a new target for anti-cancer drug development that is sitting at the ends of our

BioFrontiers Director attends Senate ForumSeptember’s first meeting of the Science, Technology and Policy Forum was held to zero in on a discussion of the human genome and its implications for medicine. Attendees included Dr. Ralph Cicerone,